LPAR3 and cancer: In the present study, we systematically inferred GPCR pathways activities from cancer transcriptomic datasets, with a special focus on the dysregulation of GPCR signaling axes involving the co-regulation of the expression of their direct ligands as well as biosynthetic pathways controlling ligand availability.